BRINDA MATAMANA: Open Payments
NPI 1891265930 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 9 payments from 6 companies in 2025. Trend: 2023 $344 · 2024 $956 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| pharmaand GmbH | 3 | $41 |
| TOLMAR, INC. | 2 | $40 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Geron Corporation | 1 | $27 |
| Eisai Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: Rubraca, KEYTRUDA, RYTELO, Lenvima, Trodelvy, ELIGARD.
Industry payments across TX — which companies pay providers there.
